Absence of hypercoagulability after nCoV-19 vaccination: an observational pilot study
E Campello, C Simion, C Bulato, CM Radu… - Thrombosis …, 2021 - Elsevier
Background It is still unknown whether COVID-19 vaccines induce a prothrombotic state or
increase the hypercoagulable condition in subjects with a predisposition to thrombosis.
Objectives We evaluated the coagulation profile in a series of healthy subjects who received
the first dose of the BNT162b2 or the ChAdOx1 vaccines and assessed whether
hypercoagulability developed. Patients/methods Volunteers among the staff of the University
of Padua or health care professionals in the Padua University Hospital who had received …
increase the hypercoagulable condition in subjects with a predisposition to thrombosis.
Objectives We evaluated the coagulation profile in a series of healthy subjects who received
the first dose of the BNT162b2 or the ChAdOx1 vaccines and assessed whether
hypercoagulability developed. Patients/methods Volunteers among the staff of the University
of Padua or health care professionals in the Padua University Hospital who had received …